Bob Löwenberg1, Stefan Suciu2,3,4,5,6,7,8,9,10, E Archimbaud2,3,4,5,6,7,8,9,10, H. L. Haak2,3,4,5,6,7,8,9,10, Pierre Stryckmans2,3,4,5,6,7,8,9,10, Ralph Cataldo2,3,4,5,6,7,8,9,10, A. W. Dekker2,3,4,5,6,7,8,9,10, Zwi Berneman2,3,4,5,6,7,8,9,10, A. Thyss2,3,4,5,6,7,8,9,10, J. van der Lelie2,3,4,5,6,7,8,9,10, Pieter Sonneveld2,3,4,5,6,7,8,9,10, Giuseppe Visani2,3,4,5,6,7,8,9,10, Georges Fillet11, M. Hayat2,3,4,5,6,7,8,9,10, Anne Hagemeijer2,3,4,5,6,7,8,9,10, G Solbu2,3,4,5,6,7,8,9,10, R Zittoun2,3,4,5,6,7,8,9,10
1Daniel den Hoed Cancer Center, University Hospital, Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands.
2Brussels; University Hospital, Antwerpen;
3Centre Hospitalier Universitaire, Liege, Belgium
4Dr Daniel den Hood Cancer Center, PO Box 5201, 3008 AE Rotterdam, the Netherlands;
5H6pital Edouard Herriot, Lyon; Centre A. Lacassagne, Nice; Institut Gustave Roussy,
6Hoed Cancer Center; University Hospital; Depart-ment of Cell Biology and Genetics, Erasmus University, Rotterdam; Leyen-burg Hospital, The Hague;
7Ospedale Maggiore, Milano; and
8Ospedale San Orsola, Bologna, Italy.
9University Hospital, Utrecht; University Hospi-tal, Amsterdam, the Netherlands; European Organization for Research and Treatment of Cancer Data Center, Institut Bordet,
10Villejuifl Hpital Hbtel Dieu, Paris, France;
11Université de Liège - ULiège > Département des sciences cliniques > Hématologie - Oncologie médicale